According to Bloomberg, Community Health is exploring strategic options, including a potential sale of the company. BofA/Merrill analyst Kevin Fischbeck does not view public companies as a good strategic fit for Community Health as many are focused on larger urban hospitals or prefer smaller deals. Fischbeck said other options include a private equity acquisition, a sale-leaseback to a REIT, or combination of the two. The analyst said Community Health's fundamentals have been weak, which is the biggest factor in doing a deal now as it be hard to lever company or do a sales/leaseback without better visibility into cash flows. Fischback rates Community Health an Underperform with a $10 price target.

Oppenheimer lowered the firm's price target on Community Health to $4.50 from $5.50 and keeps an Outperform rating on the shares following quarterly results. The firm notes Community Health maintained its 2024 outlook. Overall, at these levels, Oppenheimer continues to see attractive upside for long-term investors.

Reports Q1 revenue $3.14B, consensus $3.09B. On a same-store basis, admissions increased 3.8% and adjusted admissions increased 1.9%, compared to the same period in 2023. The company said, "We were pleased with our first quarter performance compared to both prior year and prior quarter. Progress was demonstrated on key operational and strategic priorities, and we remain focused on building further momentum as we pursue the opportunities available to us this year"